37 results on '"Lasla, Hamza"'
Search Results
2. Prediction of pathological response to neo-adjuvant chemotherapy using texture parameters of initial 18-FDG PET/CT in estrogen receptor positive/Her2 negative (ER+/HER2-) early breast cancer (eBC).
3. Proteomics of tumor and serum samples from isocitrate dehydrogenase‐wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?
4. Intérêt de l’outil web bc-GenExMiner en oncologie
5. Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches
6. Supplementary Data from Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy
7. Data from Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy
8. STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment
9. Abstract P5-02-37: Multi-omics approach to identify markers of resistance to endocrine therapy + CDK4/6 inhibitors in first line HR+/HER2- metastatic breast cancer (MBC) patients
10. Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
11. Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy
12. Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [18F]FDG PET/CT in Early Triple-Negative Breast Cancer
13. bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses
14. Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches
15. Abstract P4-06-11: High immune response identified as a good prognostic factor by proteomic SWATH-MS approach in 157 ER+/HER2- early breast cancer
16. Additional file 18: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
17. Additional file 29: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
18. Additional file 5: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
19. Additional file 3: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
20. Additional file 4: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
21. Additional file 9: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
22. Additional file 6: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
23. Additional file 7: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
24. Additional file 8: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
25. iTRAQ‐Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple‐Negative Breast Cancer Tumors
26. Additional file 6: of Gene-expression signature functional annotation of breast cancer tumours in function of age
27. Additional file 5: of Gene-expression signature functional annotation of breast cancer tumours in function of age
28. Additional file 8: of Gene-expression signature functional annotation of breast cancer tumours in function of age
29. Additional file 1: of Gene-expression signature functional annotation of breast cancer tumours in function of age
30. Additional file 9: of Gene-expression signature functional annotation of breast cancer tumours in function of age
31. Additional file 2: of Gene-expression signature functional annotation of breast cancer tumours in function of age
32. Additional file 7: of Gene-expression signature functional annotation of breast cancer tumours in function of age
33. Additional file 4: of Gene-expression signature functional annotation of breast cancer tumours in function of age
34. Additional file 3: of Gene-expression signature functional annotation of breast cancer tumours in function of age
35. Gene-expression signature functional annotation of breast cancer tumours in function of age
36. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response
37. Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [ 18 F]FDG PET/CT in Early Triple-Negative Breast Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.